The brain is the most complex organ of the body and it contains the greatest diversity of cell types. Collectively, the cells within the brain express the greatest number of genes encoded within our genome. Inappropriate gene expression within these cells plays a fundamental role in many neuronal diseases. Illuminating the mechanisms responsible for gene expression is key to understanding these diseases. Because of the complexity, however, there is still much to understand about the mechanisms responsible for gene expression in the brain. There are many steps required for a protein to be generated from a gene, and groups who focus on gene expression normally study a single step such as regulation of transcription, mechanisms of RNA processing or control of translation. To address this, experts were brought together at the Gene Expression in Neuronal Disease meeting in Cardiff. This forum provided the latest insights into specific stages of gene expression in the brain and encompassed the complete pathway from DNA to protein. The present article summarizes the meeting talks and related papers in this issue of Biochemical Society Transactions.
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This papers in this issue of Biochemical Society Transactions arise from our meeting Gene Expression in Neuronal Disease held on 16-18 July 2009 in Cardiff. We were interested in following the alterations in the fundamental processes that generate proteins from genes and how changing these processes can affect neuronal cells. Many of the alterations to these basic and often universal processes cause specific diseases and phenotypes. We were interested in the broad range of these diseases and in understanding their biochemical mechanisms. This is particularly pertinent now as we are entering an era when the underlying complex genetic causes of many common diseases that affect the nervous system are starting to be unravelled.
Hardy et al. [1] (pp. 1276-1277) describe an ambitious project to quantify changes in transcript levels across different areas of the human brain. In keeping with observations that many mutations do not result in protein coding changes, Hardy et al. [1] propose to discover how common genetic variability influences gene expression levels and how this is associated with disease risk.
Mutations in regulatory factors, such as transcription factors, also produce changes in gene expression levels. Vernes and Fisher [2] (pp. 1263-1269) investigate how a specific Key words: brain, gene expression, neuronal disease, RNA, transcription factor, translation. Abbreviations used: CACH, childhood ataxia with central nervous system hypomyelination; eEF1A2, eukaryotic elongation factor 1A2; FOXP2, forkhead box P2; VWM, vanishing white matter. 1 To whom correspondence should be addressed (email jonesl1@Cardiff.ac.uk).
change in one such transcription factor, FOXP2 (forkhead box P2), affects a complex phenotype, language. FOXP2 has profound effects on several aspects of language presentation and was used to illustrate how understanding of Mendelian disorders can be used to investigate complex neurological phenotypes. The network of genes altered by FOXP2 seems likely to underpin other language-related phenotypes. Bithell et al. [3] (pp. 1270-1275) investigate a second Mendelian disorder which also has a profound transcriptional defect. They illustrate the processes that may underlie this defect in Huntington's disease and relate this to another transcription factor, REST (repressor element 1-silencing transcription factor). Here, the widespread defect in transcription appears to be a result of the mutant Huntingtin protein interacting with transcription factors rather than being a transcription factor itself.
Once a gene is transcribed, the RNA is subject to a series of processing events to produce a mature mRNA. Articles by Jensen et al. [4] (pp. 1311-1315) and Lee and Cooper [5] (pp. 1281-1286) address defects in RNA splicing that cause neuronal disease. Jensen et al. [4] outline the complexity of splicing and spliceosome regulation and relate genetic changes that alter splicing regulation to disease phenotypes. Lee and Cooper [5] review the splicing and other post-transcriptional deficits that underlie myotonic dystrophy. They describe how expanded tandem nucleotide repeats within the affected mRNA sequesters one RNA-binding protein while up-regulating another, resulting in multiple pleiotropic disease manifestations. Ule [6] (pp. 1278-1280) discussed recent methodologies that may be applied to understanding neurological conditions. These techniques identify the mRNAs bound or regulated by specific RNA-binding proteins, thus providing a global overview of the effects of an individual post-transcriptional regulator. Mature processed mRNAs are subject to surveillance pathways such as nonsense-mediated decay that targets mRNAs for destruction. Maquat and Gong [7] (pp. 1287-1292) describe how this pathway is related to Staufen-mediated mRNA decay, resulting in competition between these pathways, the balance of which is altered during and contributes to myoblast differentiation.
The final stage in the gene to protein path is translation and Abbott et al. [8] (pp. 1293-1297) and Pavitt and Proud [9] (pp. 1298-1310) address instances where alterations in the basal translation factors cause neuronal disease phenotypes. Pavitt and Proud [9] discuss how mutations that affect factors involved in translation initiation, a fundamental process in all cells, results in the recessive Mendelian disorder VWM (vanishing white matter) or CACH (childhood ataxia with central nervous system hypomyelination). The extensive roles that translation factors including eIF2B (eukaryotic initiation factor 2B), which is mutated in VWM/CACH, play in learning and memory was also highlighted. Abbott et al. [8] showed that loss of a translation elongation factor, eEF1A2 (eukaryotic elongation factor 1A2), causes motor neuron degeneration in mice, providing a good model for motor neuron disease. Expression of eEF1A2 is highly restricted compared with the more ubiquitous eEF1A1, and fits well with the onset of the phenotype. The properties of eEF1A2 may be subtly different from those of eEF1A1, but it remains to be determined whether this difference reflects the translation role of eEF1A or an alternative 'moonlighting' role. These reviews show that alterations in the fundamental processes affecting the ways genes give rise to proteins can cause neuronal disease. Many of the phenotypes we use here to illustrate those processes are single gene disorders, but they affect the expression of many genes. They also highlight that many of the proteins which function in gene expression are multifunctional, affecting several steps in the gene expression pathway or having entirely distinct other roles, adding additional layers of complexity. The mechanisms highlighted by these studies are likely to be affected in many neuronal diseases with more complex genetic underpinnings, such as the common neurodegenerative and psychiatric diseases. They illustrate the alteration in basic mechanisms that can give rise to specific neuronal phenotypes. Inevitably, a greater understanding of the mechanisms regulating transcription, RNA processing and translation and mRNA stability will further our understanding of many neuronal diseases.
